Cassava Sciences (SAVA)
(Delayed Data from NSDQ)
$27.42 USD
-2.01 (-6.83%)
Updated Oct 1, 2024 04:00 PM ET
After-Market: $28.01 +0.59 (2.15%) 7:58 PM ET
4-Sell of 5 4
D Value F Growth C Momentum F VGM
Industry / Sector Report
Industry : Medical - Drugs
Zacks Industry Rank
Top 37% (88 out of 252)Zacks Sector Rank
Top 13% (2 out of 16)Recommendations and Estimates
Company | Industry | SP500 | |
---|---|---|---|
Average Recommendation (1=Buy, 5=Sell) | 2.00 | 1.56 | 9.99 |
Current Quarter Estimate | -1.37 | 0.26 | 61.00 |
Year Ago Quarter Estimate | -0.61 | -0.05 | 54.84 |
Next Quarter Estimate | -1.56 | -1.84 | 63.00 |
Next Year Estimate | NA | 12.89 | 275.00 |
Growth Rates
Company | Industry | SP500 | |
---|---|---|---|
This Year | -42.67 | 20.00 | 15.67 |
Next Year | NA | 17.00 | 11.34 |
Last 5 Years | -252.20 | 7.80 | 8.10 |
Next 5 Years | NA | 21.30 | NA |
Financials
Company | Industry | |
---|---|---|
Price/Earnings (TTM) | NA | -2.09 |
Price/Book (MRQ) | 7.47 | 1.51 |
Price/Cash Flow (MRFY) | NA | 8.65 |
Dividend Yield | 0.00% | 0.00% |
Net Profit Margin (TTM) | NA | -56.43% |
Return on Equity (TTM) | -88.23% | -58.58% |
Debt to Equity (MRQ) | NA | 0.00 |
MRQ = Most Recent Quarter
TTM = Trailing Twelve Months
MRFY = Most Recent Fiscal Year
Note: Company and S&P 500 ratios relating to share price calculated daily; all others calculated weekly or in accordance with company earnings announcement. Industry medians calculated weekly.